Company news
Eledon Pharmaceuticals, Inc. news in 2021
Eledon Pharmaceuticals, Inc.'s news releases, calls and decks from 2021, newest first.
Eledon Pharmaceuticals Reports Third Quarter 2021 Operating and Financial Results
November 10, 2021
Eledon Pharmaceuticals Announces Participation in November Conferences
November 3, 2021
Eledon Pharmaceuticals to Release Third Quarter Financial Results on Thursday, November 11, 2021
October 31, 2021
Eledon Pharmaceuticals Announces Presentation on AT-1501 at the Virtual 2021 Northeast Amyotrophic Lateral Sclerosis Consortium
October 6, 2021
Eledon Pharmaceuticals Announces Upcoming Presentation on AT-1501 at the Virtual 2021 International Pancreas and Islet Transplantation Association Congress
October 4, 2021
Eledon Pharmaceuticals Reports Second Quarter 2021 Operating and Financial Results
August 11, 2021
Eledon Pharmaceuticals Receives Health Canada Approval to Commence Human Trials to Evaluate AT-1501 in Kidney Transplantation
July 25, 2021
Eledon Pharmaceuticals Appoints Jan Hillson, M.D., to its Board of Directors
July 1, 2021
Eledon Pharmaceuticals Reports First Quarter 2021 Operating and Financial Results
May 12, 2021
Eledon Pharmaceuticals Announces Upcoming Presentations on AT-1501 at the Virtual 2021 American Transplant Congress
May 4, 2021
Eledon Pharmaceuticals to Release First Quarter Financial Results on Thursday, May 13, 2021
May 3, 2021
Eledon Pharmaceuticals Announces Update on Development Strategy for AT-1501 in Renal Transplantation
April 25, 2021
Eledon Pharmaceuticals Continues to Bolster Leadership Team with Addition of Two More Key Executives
April 18, 2021
Eledon Pharmaceuticals to Release Fourth Quarter and Full-Year Financial Results on Tuesday, March 30
March 22, 2021
Eledon Pharmaceuticals Strengthens Leadership Team with Chief Medical Officer and Chief Financial Officer Hires
March 14, 2021